Boryung Pharm (003850) - Total Liabilities

Latest as of September 2025: ₩537.67 Billion KRW ≈ $364.37 Million USD

Based on the latest financial reports, Boryung Pharm (003850) has total liabilities worth ₩537.67 Billion KRW (≈ $364.37 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Boryung Pharm long-term investment allocation to see how much of total assets are deployed in long-term investments.

Boryung Pharm - Total Liabilities Trend (2009–2024)

This chart illustrates how Boryung Pharm's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see balance sheet size of Boryung Pharm.

Boryung Pharm Competitors by Total Liabilities

The table below lists competitors of Boryung Pharm ranked by their total liabilities.

Company	Country	Total Liabilities
Guizhou Transp Planning SHG:603458	China	CN¥2.70 Billion
Citi Trends Inc NASDAQ:CTRN	USA	$370.85 Million
Duniec TA:DUNI	Israel	ILA1.31 Billion
Armada Hflr Pr NYSE:AHH	USA	$1.72 Billion
AS Tallink Grupp F:T5N	Germany	€600.30 Million
Figeac Aero SA PA:FGA	France	€619.70 Million
Hansen Technologies Ltd AU:HSN	Australia	AU$221.29 Million
Metrogas SA BA:METR	Argentina	AR$429.73 Billion

Liability Composition Analysis (2009–2024)

This chart breaks down Boryung Pharm's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Boryung Pharm (003850) balance sheet quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.39	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.66	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.40	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Boryung Pharm's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Boryung Pharm (2009–2024)

The table below shows the annual total liabilities of Boryung Pharm from 2009 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩379.58 Billion ≈ $257.24 Million	+3.64%
2023-12-31	₩366.26 Billion ≈ $248.21 Million	-2.58%
2022-12-31	₩375.97 Billion ≈ $254.79 Million	+6.11%
2021-12-31	₩354.33 Billion ≈ $240.12 Million	+15.15%
2020-12-31	₩307.71 Billion ≈ $208.53 Million	+36.96%
2019-12-31	₩224.68 Billion ≈ $152.26 Million	+15.86%
2018-12-31	₩193.91 Billion ≈ $131.41 Million	+26.86%
2017-12-31	₩152.86 Billion ≈ $103.59 Million	-24.53%
2016-12-31	₩202.55 Billion ≈ $137.27 Million	+59.22%
2012-12-31	₩127.21 Billion ≈ $86.21 Million	+2.25%
2011-12-31	₩124.42 Billion ≈ $84.32 Million	+13.68%
2010-12-31	₩109.45 Billion ≈ $74.17 Million	+107.40%
2009-12-31	₩52.77 Billion ≈ $35.76 Million	--

About Boryung Pharm

KO:003850 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$487.21 Million

₩718.93 Billion KRW

Market Cap Rank

#12456 Global

#353 in Korea

Share Price

₩8510.00

Change (1 day)

-2.96%

52-Week Range

₩7570.00 - ₩10680.00

All Time High

₩21257.60